MedPath

Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy

The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block

Phase 4
Completed
Conditions
The Duration of Motor Block May Vary Between 12-36 Hrs
Interventions
First Posted Date
2011-01-10
Last Posted Date
2017-04-06
Lead Sponsor
Northwestern University
Target Recruit Count
142
Registration Number
NCT01272921
Locations
🇺🇸

Northwestern University, Feingberg School of Medicine, Chicago, Illinois, United States

Comparison of the Analgesic Effect Between Intrathecal Morphine and IV-fentanyl Patient Controlled Analgesia (ITM-IVPCA) and Epidural PCA (PCEA) in Patients Undergoing Gastrectomy -Randomized Allocation Study-

Phase 4
Completed
Conditions
Gastric Cancer
Interventions
First Posted Date
2010-11-04
Last Posted Date
2011-08-16
Lead Sponsor
Yonsei University
Target Recruit Count
59
Registration Number
NCT01234272
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations

Not Applicable
Completed
Conditions
Hepatectomy
Pain
Metastasis
Interventions
Drug: Physiological serum
Drug: Ropivacaine
First Posted Date
2010-09-03
Last Posted Date
2015-04-21
Lead Sponsor
Centre Leon Berard
Target Recruit Count
85
Registration Number
NCT01194843
Locations
🇫🇷

Centre Léon Bérard, LYON Cedex 08, France

Bilateral Superficial Cervical Block for Thyroidectomy

Phase 4
Conditions
Cervical Pain
Interventions
Drug: 0.9% saline
Drug: Ropivacaine
First Posted Date
2010-07-29
Last Posted Date
2010-07-29
Lead Sponsor
Lifecenter Hospital
Target Recruit Count
120
Registration Number
NCT01171885
Locations
🇧🇷

Lifecenter Hospital, Belo Horizonte, Minas Gerais, Brazil

Comparison of Levobupivacaine and Ropivacaine for Femoral Neural Block

Phase 4
Terminated
Conditions
Pain
Arthroplasty, Replacement, Knee
Interventions
First Posted Date
2010-07-29
Last Posted Date
2018-05-09
Lead Sponsor
NHS Tayside
Target Recruit Count
14
Registration Number
NCT01172197

Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type

Phase 4
Completed
Conditions
Hip Fracture of Intertrochanteric Type
Interventions
Drug: Ropivacaine
Drug: Saline
First Posted Date
2010-05-07
Last Posted Date
2011-03-16
Lead Sponsor
Odense University Hospital
Target Recruit Count
74
Registration Number
NCT01119209
Locations
🇩🇰

Odense University Hospital, Odense, DK, Denmark

Thoracic Paravertebral Block for Postoperative Analgesia After Video-assisted Thoracic Surgery.

Phase 3
Completed
Conditions
Pain, Postoperative
Interventions
First Posted Date
2010-03-09
Last Posted Date
2015-03-19
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
90
Registration Number
NCT01082744
Locations
🇫🇷

Hospices Civils de Lyon, Hopital Louis Pradel, Department of Anesthesiology, Bron, France

Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia

First Posted Date
2010-03-01
Last Posted Date
2014-01-22
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
95
Registration Number
NCT01077752
Locations
🇫🇷

Departement d'Anesthesie-Reanimation, Hopital Saint-Antoine, Paris, France

Local Anesthesia Versus Saline Serum in Surgical Incision of Colorectal or Hepatic Surgery

Phase 4
Completed
Conditions
Postoperative Pain
Surgery
Postoperative Complications
Interventions
Drug: ropivacaine
Drug: saline solution
First Posted Date
2010-02-25
Last Posted Date
2017-03-27
Lead Sponsor
Hospital Universitari de Bellvitge
Target Recruit Count
225
Registration Number
NCT01075646
Locations
🇪🇸

Anesthesiology Service of Univeritary Hospital of Bellvitge, Hospitalet . Barcelona, Barcelona, Spain

Topical Formulations of Liposomal Local Anesthetics

Phase 1
Completed
Conditions
Administration, Topical Drug
Administration, Topical
Anesthetic Drugs
Interventions
First Posted Date
2010-01-22
Last Posted Date
2010-01-22
Lead Sponsor
University of Campinas, Brazil
Target Recruit Count
80
Registration Number
NCT01054547
Locations
🇧🇷

Piracicaba Dental School, Piracicaba, Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath